DEFERASIROX
- Product NDC
- 46708-411
- 11-digit product format
- 467080411
- Labeler code
- 46708
- Product ID
- 46708-411_d58c204e-f996-4969-85c7-3fbe078bf6a8
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- DEFERASIROX
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Alembic Pharmaceuticals Limited
- Application
- ANDA211824
- Marketing category
- ANDA
- Marketing start
- 2020-06-15
- Substance
- DEFERASIROX
- Active strength
- 180 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| V8G4MOF2V9 | DEFERASIROX | 201530-41-8 | DEFERASIROX |
Packages
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 46708-411-30 | 46708041130 | 30 TABLET, FILM COATED in 1 BOTTLE (46708-411-30) | 2020-06-15 | No | No | Historical |
| 46708-411-91 | 46708041191 | 1000 TABLET, FILM COATED in 1 BOTTLE (46708-411-91) | 2020-06-15 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| DEFERASIROX | Alembic Pharmaceuticals Limited | 2023-01-30 | Human Prescription Drug Label | 3 |